ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Corrective Action and Preventive Actions Muhammad Asim Niazi
February 19, 2024Corrective Action & Preventive Action in the pharma industry is more than a regulatory and standardization requirement. -
Case study of FDA warning letters Muhammad Asim Niazi
January 23, 2024A warning letter is a part of communication by the FDA with the manufacturer to share their finding to remove the discrepancy found during their inspection and inform the status of the manufacturer's measures.
Pharma Sources Insight January 2025
